Shelter Pharma Ltd Q4 FY26 results deck summary

Results deck of 17 Jun 2026, summarised by AI from the filing.

Shelter Pharma FY26 revenue from operations was ₹73.13 cr and it targets annual revenues of ₹200 cr by 2030.

Key takeaways

1. FY26 revenue FY26 revenue from operations was ₹73.13 cr (FY25: ₹50.66 cr, FY24: ₹40.02 cr).
2. Vision 2030 Management targets annual revenues of ₹200 cr by the year 2030 through capacity expansion, product launches and global market penetration.
3. Margin trend FY26 EBITDA margin was 17.39%, down from 19.88% in FY25 and 21.44% in FY24.
4. Capacity The company acquired land near Himmatnagar, Gujarat, for a second manufacturing facility to enhance production capacity.
5. Margin risk EBITDA margin and net margin declined over FY24 to FY26.

Original filing on BSE

Shelter Pharma Ltd earnings call, investor presentation and press release summaries

• Q4 FY26: Earnings call (19 Jun 2026), Results deck (17 Jun 2026)